CLGN:NASDAQ, CollPlant Biotechnologies Ltd.

Why CLGN stock fell on November 13

CollPlant Biotechnologies Ltd. fell 21.3% on Friday, November 13, 2026, on 73,741 shares. Headlines around the move:

CLGN stock overview

CollPlant Biotechnologies Ltd. (CLGN:NASDAQ) closed at $4.64 on November 12, 2026, up 17.17% on the day. The stock trades 79.4% below its 52-week high of $22.50 and 75.8% above its 52-week low of $2.64. Over the past year, it lost 76.5%. CollPlant Biotechnologies Ltd. is part of the Health Care sector.

Key figures

Price
$4.64
Day change
+17.17%
Volume
125,267
Average volume
376,398
Market cap
14M+
52-week range
$2.64 – $22.50
50-day average
$3.84
200-day average
$4.54

Price action over the past year

In 252 trading sessions since November 13, 2025, CLGN closed higher on 107 days (42%). Its best day was July 6, 2026 (+25.88%) and its worst was February 5, 2026 (-53.42%). The stock moved 10% or more in a single session 28 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

CLGN news

About CollPlant Biotechnologies Ltd.

Collplant Holdings Ltd is a biotechnology company focused on regenerative medicine. It focused on developing & commercializing tissue repair products. Its products are based on recombinant human collagen produced from genetically-modified tobacco plants.

Similar stocks

Find more stocks like CLGN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.